World's Best Scientists 2026 revealed!
Yoshiyuki Ohsugi

Yoshiyuki Ohsugi

D-Index & Metrics

Immunology

D-Index
51
Citations
11903
World Ranking
4127
National Ranking
92

Yoshiyuki Ohsugi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yoshiyuki Ohsugi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 142 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yoshiyuki Ohsugi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshiyuki Ohsugi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 51 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yoshiyuki Ohsugi is a researcher affiliated with Roche (Switzerland) located in Switzerland. Their work is situated within the pharmaceutical industry, contributing to research and development efforts at this prominent company.

While specific details about their publications such as recent papers, frequent co-authors, and main fields of study are not available, the professional association with Roche indicates involvement in applied biomedical sciences or related areas typical for a pharmaceutical environment. The absence of listed co-authors or frequent publication venues suggests a possible focus on internal research or proprietary projects rather than frequent publication in external academic journals.

No records of book publications or awards have been noted for Yoshiyuki Ohsugi. This could reflect a primary emphasis on research and development activities rather than broader academic dissemination or recognition through formal awards.

The profile does not include specific information about research themes or subfields of study, and there are no available data on main topics of work. This implies that publicly accessible information about the precise scientific interests and contributions of Yoshiyuki Ohsugi is limited or not documented in conventional research databases.

Overall, Yoshiyuki Ohsugi represents a scientist working within the context of a global pharmaceutical company, potentially contributing to product development, clinical research, or related scientific work aligned with Roche's operational focus. Their career illustrates an industry-based pathway consistent with researchers embedded in corporate environments where the dissemination of research may be directed toward internal goals or proprietary innovation.

Best Publications

  • Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.

    T Tamura;N Udagawa;N Takahashi;C Miyaura

  • Reshaping a Human Antibody to Inhibit the Interleukin 6-dependent Tumor Cell Growth

    Koh Sato;Masayuki Tsuchiya;Jośe Saldanha;Yasuo Koishihara

  • Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

    Masashi Narazaki;Kiyoshi Yasukawa;Takashi Saito;Yoshiyuki Ohsugi

  • IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.

    Satoshi Serada;Minoru Fujimoto;Masahiko Mihara;Nobuo Koike

  • Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family.

    Masahiko Mihara;Keiko Kasutani;Makoto Okazaki;Akito Nakamura

  • Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis

    Nobuhiro Takagi;Masahiko Mihara;Yoichiro Moriya;Norihiro Nishimoto

  • Blockade of Interleukin-6 Receptor Suppresses Reactive Astrogliosis and Ameliorates Functional Recovery in Experimental Spinal Cord Injury

    Seiji Okada;M. Nakamura;Y. Mikami;T. Shimazaki

  • Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

    Minoru Fujimoto;Satoshi Serada;Masahiko Mihara;Yasushi Uchiyama

  • INTERLEUKIN-6 (IL-6) INDUCES THE PROLIFERATION OF SYNOVIAL FIBROBLASTIC CELLS IN THE PRESENCE OF SOLUBLE IL-6 RECEPTOR

    M. Mihara;Y. Moriya;T. Kishimoto;Y. Ohsugi

  • Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis

    Takeru Yoshimura;Koh Hei Sonoda;Nobuyuki Ohguro;Yoshiyuki Ohsugi

  • Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons.

    Toru Yamashita;Kazunobu Sawamoto;Shigeaki Suzuki;Norihiro Suzuki

  • Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component

    Tadamitsu Kishimoto;Masahiko Mihara;Yoichiro Moriya;Yoshiyuki Ohsugi

  • ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1

    Yuichi Hirata;Naoki Kimura;Koh Sato;Yoshiyuki Ohsugi

  • Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6

    Chisato Miyaura;Kenichiro Kusano;Toshihide Masuzawa;Osamu Chaki

  • Purification and characterization of soluble human IL-6 receptor expressed in CHO cells.

    Kiyoshi Yasukawa;Takashi Saito;Takeshi Fukunaga;Yasuo Sekimori

  • Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

    Youichi Mizutani;Benjamin Bonavida;Yasuo Koishihara;Ken-ichi Akamatsu

  • Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

    Hitoshi Tai;Chisato Miyaura;Carol C. Pilbeam;Tatsuya Tamura;Tatsuya Tamura

  • Muscle Undergoes Atrophy in Association with Increase of Lysosomal Cathepsin Activity in Interleukin-6 Transgenic Mouse

    T. Tsujinaka;C. Ebisui;J. Fujita;M. Kishibuchi

  • Anti‐interleukin‐6 receptor antibody prevents muscle atrophy in colon‐26 adenocarcinoma‐bearing mice with modulation of lysosomal and ATP‐ubiquitin‐dependent proteolytic pathways

    Junya Fujita;Toshimasa Tsujinaka;Masahiko Jano;Chikara Ebisui

  • Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization

    Kanako Izumi-Nagai;Norihiro Nagai;Yoko Ozawa;Masahiko Mihara

Frequent Co-Authors

Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Tadanori Mayumi
Tadanori Mayumi Kobe Gakuin University
Shinsaku Nakagawa
Shinsaku Nakagawa Osaka University
Masafumi Takahashi
Masafumi Takahashi Jichi Medical University
Naoki Okada
Naoki Okada Osaka University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Kiyoshi Yasukawa
Kiyoshi Yasukawa Kyoto University
Hideyuki Okano
Hideyuki Okano Keio University
Tetsuji Naka
Tetsuji Naka Kōchi University
Minoru Fujimoto
Minoru Fujimoto Kōchi University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare and nursing fields that offer specialized online degrees. For those interested in advanced practice roles, exploring which nurse practitioner program is easiest can help streamline your educational journey without compromising quality. This consideration is crucial for balancing rigorous coursework with clinical experience.

Specifically, programs like the top pmhnp programs offer valuable training for those drawn to psychiatric mental health, an area closely linked to immunological research and patient care. These programs often boast impressive clinical placement rates, ensuring hands-on experience that is essential for licensure and practice.

Cost is another major factor for students exploring online options. Identifying the cheapest psych np programs can alleviate financial barriers while maintaining accreditation and educational standards. Affordable programs allow students to focus more on mastering their specialty areas rather than worrying about debt.

Lastly, understanding future earning potential is important when choosing a career path. Insights into how much does a dnp make, especially by state, can guide decisions on which programs to pursue and where to practice post-graduation. This financial perspective helps align one's passion for immunology with sustainable career outcomes.

Best Scientists Citing Yoshiyuki Ohsugi

Trending Scientists

Recently Published Articles